Partnering for progress: A decade of trust in Devyser CFTR
With the IVDR transition approaching, European clinical laboratories are preparing for changes that...
In this case study, Dr. Papasavva describes her laboratory’s journey from traditional thalassemia testing to state-of-the-art NGS technology and what a difference this has made in their daily work.
Infographic
This infographic details how next-generation sequencing
(NGS) can be used to help overcome the challenges and provide fast and accurate cystic fibrosis testing.
Moreover, shifting demographics are also driving a need for extended CFTR analysis and the value of sequencing in establishing global equitable CF diagnostics.
With the IVDR transition approaching, European clinical laboratories are preparing for changes that...
Read More
We spoke with Dr. Andrew Purvis, Clinical Scientist for West of Scotland Centre for Genomic...
Read More
Devyser has secured a CFTR NGS proposal with UNC Hospitals. The proposal with UNC Hospitals is...
Read More
On October 26th, we hosted an insightful webinar by Prof. Milan Macek (M.D., DSc.), where he...
Read More